Comparative Pharmacology
Head-to-head clinical analysis: ROGAINE FOR MEN versus ROGAINE FOR WOMEN.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ROGAINE FOR MEN versus ROGAINE FOR WOMEN.
ROGAINE (FOR MEN) vs ROGAINE (FOR WOMEN)
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Minoxidil is a potassium channel opener that hyperpolarizes vascular smooth muscle cells, leading to vasodilation and increased cutaneous blood flow. It also stimulates hair follicles by prolonging the anagen phase and increasing follicular size via activation of prostaglandin synthesis and upregulation of vascular endothelial growth factor (VEGF).
Minoxidil is a potassium channel opener. It causes vasodilation by opening ATP-sensitive potassium channels in vascular smooth muscle cells, leading to hyperpolarization and relaxation of arteriolar smooth muscle. This improves blood flow to hair follicles and prolongs the anagen phase of hair growth, possibly by increasing vascular endothelial growth factor (VEGF) and other growth factors.
1 mL of 5% solution applied topically to the scalp twice daily (total daily dose 2 mL).
Apply 1 mL of 2% minoxidil solution topically to the scalp twice daily (total 2 mL per day).
None Documented
None Documented
Terminal elimination half-life is approximately 4.2 hours (range 2.5–5.5 hours) in patients with normal renal function. However, the pharmacodynamic half-life (duration of antihypertensive effect) is longer, correlating with its prolonged tissue binding.
The terminal elimination half-life of minoxidil is approximately 4.2 hours (range 2–7 hours) following topical application, but the pharmacodynamic half-life (duration of drug presence in the skin and hair follicle) is longer, estimated at 24 hours. For oral minoxidil, the terminal half-life averages 4.5 hours (range 3–7 hours).
Approximately 60% of absorbed minoxidil is metabolized, primarily by conjugation with glucuronic acid. The remaining 40% is excreted unchanged in urine. Renal excretion is the major route, with unchanged drug and metabolites eliminated via the kidneys. Fecal excretion accounts for <3%.
Renal excretion of unchanged minoxidil and its glucuronide conjugates accounts for approximately 95% of the absorbed dose; about 5% is eliminated unchanged in feces via biliary excretion.
Category C
Category C
Hair Growth Agent
Hair Growth Agent